ISSN (Print): 1573-3947 ISSN (Online): 1875-6301 Volume 17, 4 Issues, 2021
Download PDF Flyer
Open Access Funding Promote Your Article
ISSN (Print): 1573-3947 ISSN (Online): 1875-6301
Aims & Scope Abstracted/Indexed in
Emerging Sources Citation Index (ESCI) by Clarivate Analytics, Scopus, EMBASE, Chemical Abstracts Service/SciFinder, Cambridge Scientific Abstracts (CSA)/ProQuest, Scilit, ChemWeb, Google Scholar, EMNursing, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, PubsHub, Index Copernicus, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, Ulrich's Periodicals Directory, JournalTOCs, QOAM, ERA 2018 and Dimensions.
Submit Abstracts / Manuscripts Online Animated Abstract Submission
View Full Editorial Board
Journal Home Editorial Policies Publishing Ethics Self Archiving Policies Reviewer Guidelines Instructions for Authors Free Copies Online Open Access Articles Most Cited Articles Advertise With Us Most Accessed Articles Highlighted Article Trial Requests Library Recommendation Most Popular Articles Thematic Issues Special Issue Submission Subscribe
Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published. Multiple issue copies at discounted rates.
"Our team has found the articles in current cancer therapy reviews to be very insightful and an accurate representation of the present state-of-the-art for academic and practicing radiation medicine physicians." Charles R. Thomas Univ. of Texas Health Science Center, USA
Submit Abstract via Email Download Description
M Sachin (School of Biosciences and Technology, VIT University, Vellore, Tamil Nadu, India.)
Drug Delivery Approaches for Doxorubicin in the Management of Cancers open Access plus
Volume: 16 Issue: 4 Pp: 320-331 Manish Vyas, Daniel A. Simbo, Mohd. Mursalin, Vijay Mishra, Roqia Bashary and Gopal L. Khatik* DOI:10.2174/1573394716666191216114950
MiR-492 as an Important Biomarker for Early Diagnosis and Targeted Treatment in Different Cancers open Access plus
Volume: 16 Issue: 4 Pp: 269-275 Eskandar Taghizadeh, Forough Taheri, Daryoush Rostami, Pedram G. Renani , Gordon A. Ferns, Alireza Pasdar* and Majid G. Mobarhan* DOI:10.2174/1573394716666200309124048
Exploring Nanoemulsion for Liver Cancer Therapy open Access plus
Volume: 16 Issue: 4 Pp: 260-268 Tanmay Upadhyay, Vaseem A. Ansari*, Usama Ahmad, Nazneen Sultana and Juber Akhtar DOI:10.2174/1573394716666200302123336
A Comparison of Ultrasound and Fluoroscopy-guided Celiac Plexus Neurolysis in Patients with Pancreatic Cancer open Access plus
Volume: 16 Issue: 3 Pp: 246-252 Khadeja M. Elhossieny*, Waseem M. Seleem, Sherief Abd-Elsalam, Tamer Haydara and Nashwa Mohamed El Gharbawy DOI:10.2174/1573394715666190904091145
New Researches about Combinatorial Therapeutic Regimen on Cancer Treatment open Access plus
Volume: 16 Issue: 2 Pp: 97-109 Xinjia He, Qiaqia He*, Lihua Wang and Xiaofei He DOI:10.2174/1573394715666190906125014
Molecular Pathways, Screening and Follow-up of Colorectal Carcinogenesis: An Overview open Access plus
Volume: 16 Issue: 2 Pp: 88-96 Eskandar Taghizadeh, Seyed M.G. Hayat, Rhonda J. Rosengren , Daryoush Rostami, Hamed Abdolkarimi and Amirhossein Sahebkar * DOI:10.2174/1573394715666190730111946
Development, Characterization and Anticancer Evaluation of Silver Nanoparticles from Dalbergia sissoo Leaf Extracts open Access plus
Volume: 16 Issue: 2 Pp: 145-151 Aakash Deep*, Mitali Verma, Rakesh K. Marwaha, Arun K. Sharma and Beena Kumari DOI:10.2174/1573394715666190820150651
Dickkopf-1 and β-catenin as Biomarkers for Early Diagnosis of Hepatocellular Carcinoma open Access plus
Volume: 16 Issue: 2 Pp: 136-144 Amal A. Mohamed, Hala M. Ghanem, Maha M. Kamal, Rehab Ahmed, Naglaa K. Madkour, Dina Abdou, Soha M. Talima, Nehad Hawash and Sherief Abd-Elsalam* DOI:10.2174/1573394715666191122094659
Demographic and Clinical Evaluation of Patients with Pancreatic Cancer in Mashhad University of Medical Sciences During 2002-2013 open Access plus
Volume: 16 Issue: 2 Pp: 127-135 Mina A. Rad, Azar Fanipakdel, Hassan Vossoughinia, Maliheh Dadgarmoghaddam, Benyamin Esmaeili, Amir H. Jafarian, Masoumeh Salari* and Abdollah Firoozi DOI:10.2174/1573394715666190422123430
Brachial Plexopathy as a Complication of Radiotherapy: A Systematic Review open Access plus
Volume: 16 Issue: 2 Pp: 110-120 Dheyauldeen Shabeeb, Ahmed E. Musa , Mansoor Keshavarz, Ehsan Mihandoust, Gholamreza Hassanzadeh , Mohammad R. Hadian, Alireza Shirazi and Masoud Najafi * DOI:10.2174/1573394715666190724102937
Virtual Screening of Novel Hybrid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Exploring Multiple Targeted Cancer Therapy by an In Silico Approach open Access plus
Volume: 16 Issue: 1 Pp: 70-77 Ashish P. Shah* and Chhagan N. Patel DOI:10.2174/1573394715666190618114748
Cancer Immunotherapy: An Effective Tool in Cancer Control and Treatment open Access plus
Volume: 16 Issue: 1 Pp: 62-69 Kawalpreet Kaur and Gopal L. Khatik* DOI:10.2174/1573394715666190913184853
Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target open Access plus
Volume: 13 Issue: 2 Pp: 76-88 Bently P. Doonan, Kei Ohnuma, Long H. Dang, Chikao Morimoto and Nam H. Dang* DOI:10.2174/1573394713666170907160734
In Silico Study and Cytotoxicity of the Synthesized Open-chain Analogues of Antimycin A3 Against HEP-2 Laryngeal Cancer Cells open Access plus
Volume: 13 Issue: 2 Pp: 129-136 Ade Arsianti*, Fadilah Fadilah, Kusmardi Kusmardi, Gede Y. Sugiarta, Hiroki Tanimoto and Kiyomi Kakiuchi DOI:10.2174/1573394713666170712113049
Non-Melanoma Skin Cancer – Overview open Access plus
Volume: 12 Issue: 3 Pp: 142-151 Kurian Joseph DOI:10.2174/1573394713666161214124214
Roles of Tumor Microenvironment in Hepatocelluar Carcinoma open Access plus
Volume: 11 Issue: 2 Pp: 82-93 Haeng R. Seo DOI:10.2174/1573394711666151022203313
Trends in Malignant Glioma Monoclonal Antibody Therapy open Access plus
Volume: 11 Issue: 2 Pp: 102-118 Ivan Chekhonin and Olga Gurina DOI:10.2174/1573394711888150917142941
Mining the Dark Matter of the Cancer Proteome for Novel Biomarkers open Access plus
Volume: 9 Issue: 4 Pp: 265-277 Ana Paula Delgado, Pamela Brandao, Sheilin Hamid and Ramaswamy Narayanan DOI:10.2174/1573394710666140313003905
Innate Immunity and Vaccine Adjuvants: From Concepts to the Development of a Unique Adjuvant System AS04 Used for the Formulation of a Human Papillomavirus (HPV) Vaccine open Access plus
Volume: 6 Issue: 2 Pp: 126-137 Nathalie Garcon and Oberdan Leo DOI:10.2174/157339410791202574
Clinical Development of MET Targeted Therapy For Human Cancer open Access plus
Volume: 5 Issue: 4 Pp: 261-270 Nima Tirgan, Zhe Tang and Patrick C. Ma DOI:10.2174/157339409789712708
Tumor Systems Need to be Rendered Usable for a New Action-Theoretical Abstraction: The Starting Point for Novel Therapeutic Options open Access plus
Volume: 5 Issue: 4 Pp: 232-242 Albrecht Reichle DOI:10.2174/157339409789712690
Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy open Access plus
Volume: 5 Issue: 2 Pp: 111-121 Nagendra K. Prasad DOI:10.2174/157339409788166779
Runx1/AML1 is a Guardian of Hematopoietic Stem Cells open Access plus
Volume: 4 Issue: 3 Pp: 188-195 Lena Motoda, Motomi Osato and Yoshiaki Ito DOI:10.2174/157339408785294302
view more